Gene Therapy Market by Vector Type, Gene Type and Application - Global Industry Analysis & Forecast to 2027
Published On : April 2019 Pages : 142 Category: Pharma & Healthcare Report Code : HC053495
Gene Therapy Market by Vector Type (Viral vector, Non-viral vector) Gene Type (Cytokine, Suicide, Growth factors, Antigen, Tumor Suppressor, Deficiency, Receptors and Others) Application (Rare Diseases, Neurological Disorders, Oncological Disorders, Cardiovascular Diseases, Infectious disease, Other Diseases) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Gene Therapy Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Genes are made out of DNA that contains important data for making proteins that are fundamental for the human body to work ideally. Some quality transformations result in these proteins not being made accurately and can prompt hereditary disarranges. Quality treatment works by repressing, repairing, or supplanting useless qualities that reason malady with the point of restoring typical function. Gene therapy is an appealing territory for medication advancement in light of the fact that with the correct target and approach, it can address the main driver of a serious ailment.
Drivers and Restraints
The expansion in subsidizing for R&D exercises relating to quality treatment and increment in awareness with respect to quality treatment are the central point that drive the market development. Moreover, increment in government support, moral acknowledgment of quality treatment for malignant growth treatment, and ascend in pervasiveness of disease can fuel the development of the gene therapy market. However, staggering expense related with the treatment and undesirable invulnerable reactions are anticipated to hinder the market development.
Regional Insights
North America represented the biggest share of the overall industry in the quality treatment market in 2017, and is anticipated to hold its strength all through the figure time frame.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Novartis
- Applied Genetic Technologies Corporation
- NewLink Genetics Corp.
- GlaxoSmithKline PLC
- Kite Pharma, Inc.
- Genethon
- Spark Therapeutics Inc.
- Oxford BioMedica
- Bluebird bio Inc.
- Transgene SA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Gene Therapy Market, By Vector Type, Estimates and Forecast, 2017-2027 ($Million)
o Non-viral vector
o Viral vector
· Gene Therapy Market, By Gene Type, Estimates and Forecast, 2017-2027 ($Million)
o Deficiency
o Tumor Suppressor
o Antigen
o Cytokine
o Receptors
o Suicide
o Growth factors
o Others
· Gene Therapy Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Rare Diseases
o Neurological Disorders
o Oncological Disorders
o Cardiovascular Diseases
o Infectious disease
o Other
· Gene Therapy Market, By Key Players
o Kite Pharma, Inc.
o Spark Therapeutics Inc.
o Novartis
o GlaxoSmithKline PLC,
o Applied Genetic Technologies Corporation
o NewLink Genetics Corp
o Transgene SA
o Oxford BioMedica
o Genethon
o Bluebird bio Inc.
· Gene Therapy Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Gene Therapy Market, By Country
o U.S. Gene Therapy Market
o Canada Gene Therapy Market
o Mexico Gene Therapy Market
o Europe
§ Europe Gene Therapy Market, By Country
o Germany Gene Therapy Market
o UK Gene Therapy Market
o France Gene Therapy Market
o Russia Gene Therapy Market
o Italy Gene Therapy Market
o Rest of Europe Gene Therapy Market
o Asia-Pacific
§ Asia-Pacific Gene Therapy Market, By Country
o China Gene Therapy Market
o Japan Gene Therapy Market
o South Korea Gene Therapy Market
o India Gene Therapy Market
o Southeast Asia Gene Therapy Market
o Rest of Asia-Pacific Gene Therapy Market
o South America
§ South America Gene Therapy Market
o Brazil Gene Therapy Market
o Argentina Gene Therapy Market
o Columbia Gene Therapy Market
o Rest of South America Gene Therapy Market
o Middle East and Africa
§ Middle East and Africa Gene Therapy Market
o Saudi Arabia Gene Therapy Market
o UAE Gene Therapy Market
o Egypt Gene Therapy Market
o Nigeria Gene Therapy Market
o South Africa Gene Therapy Market
o Rest of MEA Gene Therapy Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Gene Therapy Market, By Vector Type
5.1. Introduction
5.2. Global Gene Therapy Revenue and Market Share by Vector Type (2017-2027)
5.2.1. Global Gene Therapy Revenue and Revenue Share by Vector Type (2017-2027)
5.3. Non-viral vector
5.3.1. Global Non-viral vector Revenue and Growth Rate (2017-2027)
5.4. Viral vector
5.4.1. Global Viral vector Revenue and Growth Rate (2017-2027)
6. Gene Therapy Market, By Gene Type
6.1. Introduction
6.2. Global Gene Therapy Revenue and Market Share by Gene Type (2017-2027)
6.2.1. Global Gene Therapy Revenue and Revenue Share by Gene Type (2017-2027)
6.3. Deficiency
6.3.1. Global Deficiency Revenue and Growth Rate (2017-2027)
6.4. Tumor Suppressor
6.4.1. Global Tumor Suppressor Revenue and Growth Rate (2017-2027)
6.5. Antigen
6.5.1. Global Antigen Revenue and Growth Rate (2017-2027)
6.6. Cytokine
6.6.1. Global Cytokine Revenue and Growth Rate (2017-2027)
6.7. Receptors
6.7.1. Global Receptors Revenue and Growth Rate (2017-2027)
6.8. Suicide
6.8.1. Global Suicide Revenue and Growth Rate (2017-2027)
6.9. Growth factors
6.9.1. Global Growth factors Revenue and Growth Rate (2017-2027)
6.10. Others
6.10.1. Global Others Revenue and Growth Rate (2017-2027)
7. Gene Therapy Market, By Application
7.1. Introduction
7.2. Global Gene Therapy Revenue and Market Share by Application (2017-2027)
7.2.1. Global Gene Therapy Revenue and Revenue Share by Application (2017-2027)
7.3. Rare Diseases
7.3.1. Global Rare Diseases Revenue and Growth Rate (2017-2027)
7.4. Neurological Disorders
7.4.1. Global Neurological Disorders Revenue and Growth Rate (2017-2027)
7.5. Oncological Disorders
7.5.1. Global Oncological Disorders Revenue and Growth Rate (2017-2027)
7.6. Cardiovascular Diseases
7.6.1. Global Cardiovascular Diseases Revenue and Growth Rate (2017-2027)
7.7. Infectious disease
7.7.1. Global Infectious disease Revenue and Growth Rate (2017-2027)
7.8. Other
7.8.1. Global Other Revenue and Growth Rate (2017-2027)
8. Gene Therapy Market, By Region
8.1. Introduction
8.2. Global Gene Therapy Revenue and Market Share by Regions
8.2.1. Global Gene Therapy Revenue by Regions (2017-2027)
8.3. North America Gene Therapy by Countries
8.3.1. North America Gene Therapy Revenue and Growth Rate (2017-2027)
8.3.2. North America Gene Therapy Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Gene Therapy by Countries
8.4.1. Europe Gene Therapy Revenue and Growth Rate (2017-2027)
8.4.2. Europe Gene Therapy Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Gene Therapy by Countries
8.5.1. Asia-Pacific Gene Therapy Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Gene Therapy Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Gene Therapy by Countries
8.6.1. South America Gene Therapy Revenue and Growth Rate (2017-2027)
8.6.2. South America Gene Therapy Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Gene Therapy by Countries
8.7.1. Middle East and Africa Gene Therapy Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Gene Therapy Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Kite Pharma, Inc.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Spark Therapeutics Inc.
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Novartis
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. GlaxoSmithKline PLC,
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Applied Genetic Technologies Corporation
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. NewLink Genetics Corp
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Transgene SA
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Oxford BioMedica
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Genethon
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Bluebird bio Inc.
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Global Gene Therapy Market Competition, by Manufacturer
10.1. Global Gene Therapy Financial Overview by Manufacturer (2017-2017)
10.2. Global Gene Therapy Price By Region (2017-2017)
10.3. Top 5 Gene Therapy Manufacturer Market Share
10.4. Market Competition Trend
11. Gene Therapy Market Forecast (2017-2027)
11.1. Global Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Gene Therapy Market Forecast by Regions (2017-2027)
11.2.1. North America Gene Therapy Market Forecast (2017-2027)
11.2.1.1. United States Gene Therapy Market Forecast (2017-2027)
11.2.1.2. Canada Gene Therapy Market Forecast (2017-2027)
11.2.1.3. Mexico Gene Therapy Market Forecast (2017-2027)
11.2.2. Europe Gene Therapy Market Forecast (2017-2027)
11.2.2.1. Germany Gene Therapy Market Forecast (2017-2027)
11.2.2.2. France Gene Therapy Market Forecast (2017-2027)
11.2.2.3. UK Gene Therapy Market Forecast (2017-2027)
11.2.2.4. Russia Gene Therapy Market Forecast (2017-2027)
11.2.2.5. Italy Gene Therapy Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Gene Therapy Market Forecast (2017-2027)
11.2.3. Asia-Pacific Gene Therapy Market Forecast (2017-2027)
11.2.3.1. China Gene Therapy Market Forecast (2017-2027)
11.2.3.2. Japan Gene Therapy Market Forecast (2017-2027)
11.2.3.3. Korea Gene Therapy Market Forecast (2017-2027)
11.2.3.4. India Gene Therapy Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Gene Therapy Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Gene Therapy Market Forecast (2017-2027)
11.2.4. South America Gene Therapy Market Forecast (2017-2027)
11.2.4.1. Brazil Gene Therapy Market Forecast (2017-2027)
11.2.4.2. Argentina Gene Therapy Market Forecast (2017-2027)
11.2.4.3. Columbia Gene Therapy Market Forecast (2017-2027)
11.2.4.4. Rest of South America Gene Therapy Market Forecast (2017-2027)
11.2.5. Middle East and Africa Gene Therapy Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Gene Therapy Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Gene Therapy Market Forecast (2017-2027)
11.2.5.3. Egypt Gene Therapy Market Forecast (2017-2027)
11.2.5.4. Nigeria Gene Therapy Market Forecast (2017-2027)
11.2.5.5. South Africa Gene Therapy Market Forecast (2017-2027)
11.2.5.6. Turkey Gene Therapy Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Gene Therapy Market Forecast (2017-2027)
11.3. Gene Therapy Market Forecast by Vector Type (2017-2027)
11.3.1. Gene Therapy Forecast by Vector Type (2017-2027)
11.3.2. Gene Therapy Market Share Forecast by Vector Type (2017-2027)
11.4. Gene Therapy Market Forecast by Gene Type (2017-2027)
11.4.1. Gene Therapy Forecast by Gene Type (2017-2027)
11.4.2. Gene Therapy Market Share Forecast by Gene Type (2017-2027)
11.5. Gene Therapy Market Forecast by Application (2017-2027)
11.5.1. Gene Therapy Forecast by Application (2017-2027)
11.5.2. Gene Therapy Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Gene Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Gene Therapy Revenue and Revenue Share by Vector Type (2017-2018)
Figure Global Non-viral vector Revenue and Growth Rate (2017-2018)
Figure Global Viral vector Revenue and Growth Rate (2017-2018)
Table Global Gene Therapy Revenue and Revenue Share by Gene Type (2017-2018)
Figure Global Deficiency Revenue and Growth Rate (2017-2018)
Figure Global Tumor Suppressor Revenue and Growth Rate (2017-2018)
Figure Global Antigen Revenue and Growth Rate (2017-2018)
Figure Global Cytokine Revenue and Growth Rate (2017-2018)
Figure Global Receptors Revenue and Growth Rate (2017-2018)
Figure Global Suicide Revenue and Growth Rate (2017-2018)
Figure Global Growth factors Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Gene Therapy Revenue and Revenue Share by Application (2017-2018)
Figure Global Rare Diseases Revenue and Growth Rate (2017-2018)
Figure Global Neurological Disorders Revenue and Growth Rate (2017-2018)
Figure Global Oncological Disorders Revenue and Growth Rate (2017-2018)
Figure Global Cardiovascular Diseases Revenue and Growth Rate (2017-2018)
Figure Global Infectious disease Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Gene Therapy Revenue by Regions (2017-2018)
Figure North America Gene Therapy Growth Rate (2017-2018)
Figure North America Gene Therapy Revenue and Growth Rate (2017-2018)
Figure North America Gene Therapy by Countries (2017-2018)
Figure North America Gene Therapy Revenue (Million USD) by Countries (2017-2018)
Figure United States Gene Therapy Growth Rate (2017-2018)
Figure United States Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Gene Therapy Growth Rate (2017-2018)
Figure Canada Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Gene Therapy Growth Rate (2017-2018)
Figure Mexico Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Gene Therapy Growth Rate (2017-2018)
Figure Europe Gene Therapy Revenue and Growth Rate (2017-2018)
Figure Europe Gene Therapy by Countries (2017-2018)
Figure Europe Gene Therapy Revenue (Million USD) by Countries (2017-2018)
Figure Germany Gene Therapy Growth Rate (2017-2018)
Figure Germany Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Gene Therapy Growth Rate (2017-2018)
Figure France Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Gene Therapy Growth Rate (2017-2018)
Figure UK Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Gene Therapy Growth Rate (2017-2018)
Figure Russia Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Gene Therapy Growth Rate (2017-2018)
Figure Italy Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Gene Therapy Growth Rate (2017-2018)
Figure Rest of Europe Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Gene Therapy Growth Rate (2017-2018)
Figure Asia-Pacific Gene Therapy Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Gene Therapy by Countries (2017-2018)
Figure Asia-Pacific Gene Therapy Revenue (Million USD) by Countries (2017-2018)
Figure China Gene Therapy Growth Rate (2017-2018)
Figure China Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Gene Therapy Growth Rate (2017-2018)
Figure Japan Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Gene Therapy Growth Rate (2017-2018)
Figure Korea Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Gene Therapy Growth Rate (2017-2018)
Figure India Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Gene Therapy Growth Rate (2017-2018)
Figure Southeast Asia Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Gene Therapy Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Gene Therapy Growth Rate (2017-2018)
Figure South America Gene Therapy Revenue and Growth Rate (2017-2018)
Figure South America Gene Therapy by Countries (2017-2018)
Figure South America Gene Therapy Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Gene Therapy Growth Rate (2017-2018)
Figure Brazil Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Gene Therapy Growth Rate (2017-2018)
Figure Argentina Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Gene Therapy Growth Rate (2017-2018)
Figure Columbia Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Gene Therapy Growth Rate (2017-2018)
Figure Rest of South America Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Gene Therapy Growth Rate (2017-2018)
Figure Middle East and Africa Gene Therapy Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Gene Therapy by Countries (2017-2018)
Figure Middle East and Africa Gene Therapy Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Gene Therapy Growth Rate (2017-2018)
Figure Saudi Arabia Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Gene Therapy Growth Rate (2017-2018)
Figure United Arab Emirates Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Gene Therapy Growth Rate (2017-2018)
Figure Egypt Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Gene Therapy Growth Rate (2017-2018)
Figure Nigeria Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Gene Therapy Growth Rate (2017-2018)
Figure South Africa Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Gene Therapy Growth Rate (2017-2018)
Figure Turkey Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Gene Therapy Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Gene Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Table Kite Pharma, Inc. Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Spark Therapeutics Inc. Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novartis Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline PLC, Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Applied Genetic Technologies Corporation Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table NewLink Genetics Corp Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Transgene SA Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Oxford BioMedica Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Genethon Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bluebird bio Inc. Gene Therapy Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Gene Therapy Market Share by Manufacturer
Figure Global Gene Therapy Revenue and Market Share by Manufacturer
Table Global Gene Therapy Price by Region (2017-2017)
Figure Top 5 Gene Therapy Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Gene Therapy Revenue (Millions USD) and Growth Rate (2018-2025)
Table Gene Therapy Market Forecast by Regions (2018-2025)
Figure North America Gene Therapy Market Forecast (2018-2025)
Figure United States Gene Therapy Market Forecast (2018-2025)
Figure Canada Gene Therapy Market Forecast (2018-2025)
Figure Mexico Gene Therapy Market Forecast (2018-2025)
Figure Europe Gene Therapy Market Forecast (2018-2025)
Figure Germany Gene Therapy Market Forecast (2018-2025)
Figure France Gene Therapy Market Forecast (2018-2025)
Figure UK Gene Therapy Market Forecast (2018-2025)
Figure Russia Gene Therapy Market Forecast (2018-2025)
Figure Italy Gene Therapy Market Forecast (2018-2025)
Figure Rest of Europe Gene Therapy Market Forecast (2018-2025)
Figure Asia-Pacific Gene Therapy Market Forecast (2018-2025)
Figure China Gene Therapy Market Forecast (2018-2025)
Figure Japan Gene Therapy Market Forecast (2018-2025)
Figure Korea Gene Therapy Market Forecast (2018-2025)
Figure India Gene Therapy Market Forecast (2018-2025)
Figure Southeast Asia Gene Therapy Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Gene Therapy Market Forecast (2018-2025)
Figure South America Gene Therapy Market Forecast (2018-2025)
Figure Brazil Gene Therapy Market Forecast (2018-2025)
Figure Argentina Gene Therapy Market Forecast (2018-2025)
Figure Columbia Gene Therapy Market Forecast (2018-2025)
Figure Rest of South America Gene Therapy Market Forecast (2018-2025)
Figure Middle East and Africa Gene Therapy Market Forecast (2018-2025)
Figure Saudi Arabia Gene Therapy Market Forecast (2018-2025)
Figure United Arab Emirates Gene Therapy Market Forecast (2018-2025)
Figure Egypt Gene Therapy Market Forecast (2018-2025)
Figure Nigeria Gene Therapy Market Forecast (2018-2025)
Figure South Africa Gene Therapy Market Forecast (2018-2025)
Figure Turkey Gene Therapy Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Gene Therapy Market Forecast (2018-2025)
Figure Global Gene Therapy Forecast by Vector Type (2018-2025)
Figure Global Gene Therapy Market Share Forecast by Vector Type (2018-2025)
Figure Global Gene Therapy Forecast by Vector Type (2018-2025)
Figure Global Gene Therapy Forecast by Gene Type (2018-2025)
Figure Global Gene Therapy Market Share Forecast by Gene Type (2018-2025)
Figure Global Gene Therapy Forecast by Gene Type (2018-2025)
Figure Global Gene Therapy Forecast by Application (2018-2025)
Figure Global Gene Therapy Market Share Forecast by Application (2018-2025)
Figure Global Gene Therapy Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|